Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men

The 2018 U.S. Preventive Services Task Force (USPSTF) final recommendation states that male
patients and their providers engage in a shared-decision making process about the benefits
and harms of PSA-based screening. As characterized by the USPSTF, these conversations are
particularly important for African American men given increased ambiguity due to the lack of
PSA-based research specific to this population and increased risk of prostate cancer
mortality attributed to late stage at diagnosis and more aggressive prostate cancer
phenotypes seen in African American men.

The goal of this randomized behavioral clinical trial is to advance the translation path of
implementing the decision-making process in clinical encounters by evaluating the efficacy of
a dual-pronged intervention for Primary Care Providers and African American males to increase
shared decision making about PSA-screening versus usual care. The intervention will use
multimedia educational training materials to increase understanding of prostate cancer,
PSA-based screening, and shared decision making among patients and PCPs

Patient Inclusion Criteria:

- Receiving care at the clinical sites

- Identify as African American male

- Ages 40-69 years old

- Provider-estimated life expectancy of at least 10 years

Patient Exclusion Criteria:

- Personal history of prostate cancer at the time of consent

- Cognitive impairment that would interfere with participation in the study

- Unable to complete any aspect of the intervention within the specified time limit